SCHEMBL24309788

SCHEMBL24309788

Cn1cc(SNc2nc(Oc3ccccc3)cc(C3CCCCC3)n2)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 2/20 0.36
▸ ALOX5 P09917 2/20 0.34
▸ GPR39 O43194 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ TYRO3 Q06418 1/20 0.32
▸ CHEK1 O14757 2/20 0.32
▸ HAO1 Q9UJM8 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ TNK2 Q07912 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310582 0.89 CYP1A2 (0.34) CYP1A2CYP2C9CYP2C19TYRO3MAPK1
SCHEMBL24310334 0.89 WNT1 (0.32) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL24309828 0.88 AXL (0.33) TYRO3MEN1KMT2ATNK2AXL
SCHEMBL24309634 0.84 CACNA1B (0.33) GPR39MAPTMEN1KMT2A
SCHEMBL24309698 0.84 CDK4 (0.37) CCNA2CDK2
SCHEMBL24309693 0.84 IRAK4 (0.33) CHEK1
SCHEMBL24309680 0.84 IRAK4 (0.33) CHEK1
SCHEMBL24309688 0.83 MAPK1 (0.46) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL24309787 0.81 MAPT (0.36) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL29566649 0.80 HTR1A (0.42) CYP1A2MAPTCYP2C9CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback